© Copyright Nostre Net
Stem cells have been acknowledged for their
promising potential toward the development of various cutting-edge treatments
for a number of diseases. As such, stem cell assays have a rapidly growing
market. Stem cell assays are essentially the techniques used for analyzing
living cells by various parameters which ultimately help determine the
biochemical and cellular functioning of cells. This has immense promise in drug
development activities. Market Research Future's study of the market in its
latest report has found that the global stem cell assay market is on track to
register a highly optimistic outlook at a CAGR of 19.8% during the review
period from 2022 to 2030.
Stem cell assays are a promising part of
the biotechnology field, which is growing at a rapid pace. The prevalence of
chronic and several lifestyle diseases has compelled the growth of drug
development activities in an effort to develop effective treatments. Diseases
such as cancer and diabetes are soaring at high rates and the demand for better,
efficient and more affordable treatments are driving the market toward growth.
Healthcare expenditure across the globe is increasing, and advancement in
biotechnology and other medical technologies is highly encouraging of market
growth. Government support toward drug development for chronic diseases has
increased stem
cell assay market research.
Market Segmentation
Market structure is determined by its
various significant sections which, in the report have been segmented on the
basis of product, technology, assay, application, end-user, and region.
Products in the market include flow cytometer, cell imaging systems, automated
cell counter, kits, and others. The kits segment has been sub-segmented and
includes umbilical cord stem cells, induced pluripotent stem cell kits,
mesenchymal stem cell kits, and others.
The technology used in stem cell assays
include microfluidics-based cell trap technologies, microfabricated assisted
technology, synthetic stem cells and others
Assays in the market include cell
identification assays, cell viability & toxicity assays, cell proliferation
assays, cell apoptosis assays, and others.
Applications of stem cell assays can be
found in orthopedic & musculoskeletal spine, dermatology, cardiovascular,
central nervous system, and others.
End-users of stem cell assays include
research organizations, academic institutes, biotechnology industries, academic
institutes, and others.
Regional Analysis
The Americas have captured the dominant
share of the global market. The presence of North America in the region has had
a significant impact on the regions market share possession. The rapid adoption
of advanced medical technologies and the presence of a large patient population
for various chronic diseases drive the Americas' market. Moreover, the regions
healthcare expenditure is rising, and there are several leading players present
in the North American sub-market.
Meanwhile, growing at the fastest pace is
the Asia Pacific regional market. Gradually increasing awareness regarding
advanced medical biotechnology is strongly impacting growth in the region.
Several emerging economies in the region have a rapidly growing biotechnology
sector which fuelling market growth. Findings by the Indian Brand Equity
Foundation suggest that the Indian subcontinent has 2% of the global
biotechnology share. Several opportunities in the region are expected to lead
to market proliferation.
Key Players
Stem
Cell Assay Market players included in MRFR’s report are Cell Biolabs, Inc.,
Thermo Fisher Scientific, Hemogenix, Merck KGaA, Promega Corporation, GE
Healthcare, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cellular
Dynamics International Inc., STEMCELL Technologies Inc., and others
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Wall